This measure captures the proportion of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.
This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs. STK-3, Anticoagulation Therapy for Atrial Fibrillation/Flutter, is one of six of the measures in this set that have been reengineered as eCQMs and are included in the EHR Incentive Program and Hospital Inpatient Quality Reporting Program.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Care SettingNumerator
Patients prescribed anticoagulation therapy at hospital discharge.
DenominatorPatients with a principal diagnosis of ischemic stroke, history of atrial ablation, and current or history of atrial fibrillation/flutter.
ExclusionsDenominator Exclusions:
• Patients with comfort measures documented.
• Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.
• Patients discharged to another hospital.
• Patients who left against medical advice.
• Patients who expired.
• Patients discharged to home for hospice care.
• Patients discharged to a health care facility for hospice care.
Denominator Exceptions:
• Patients with a documented reason for not prescribing anticoagulation therapy at discharge.Testing Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationNational Quality Strategy PrioritiesEffective Communication and Care Coordination
- Risk Adjustment
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityNot Endorsed Neurology Project 2015-2016Endorsement Status
- StewardSteward Organization EmailSteward Organization Copyright
Measure specifications are in the Public Domain
LOINC(R) is a registered trademark of the Regenstrief Institute.
This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.